— Know what they know.
Not Investment Advice

EKSO

Ekso Bionics Holdings, Inc.
1W: +2.7% 1M: +8.0% 3M: +108.3% YTD: +40.0% 1Y: +49.6% 3Y: -47.0% 5Y: -89.7%
$11.42
+0.44 (+4.01%)
 
NASDAQ · Healthcare · Medical - Instruments & Supplies · $26.6M · Alpha Radar Buy · Power 52
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$26.6M
52W Range2.73-13.5
Volume17,540
Avg Volume2,196,025
Beta0.84
Dividend
Analyst Ratings
3 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOScott G. Davis
Employees61
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2014-01-17
1414 Harbour Way South
San Rafael, CA 94804
US
510 984 1761
About Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Recent Insider Trades

NameTypeSharesPriceDate
Jones Jason C P-Purchase 1,308 $11.85 2026-03-16
Wong Jerome P-Purchase 1,308 $11.85 2026-03-16
ASHER DANIEL P-Purchase 15,540 $12.30 2026-02-19
ASHER DANIEL P-Purchase 1,200 $9.60 2026-02-19
ASHER DANIEL P-Purchase 11,092 $9.14 2026-02-13

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms